SHMARQL

vandetanib

<http://www.wikidata.org/entity/Q7914515>

chemical compound
rdfs:label
"vandetanib"@en
skos:altLabel
"4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline"@en
"CH 331"@en
"Caprelsa®"@en
"N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine"@en
"N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine"@en
"Vandetanib"@en
"ZD 6474"@en
"ZD-6474"@en
"ZD6474"@en
schema:description
"chemical compound"@en
schema:dateModified "2026-11-12T15:54:53+00:00"^^xsd:dateTime
schema:version 2568331996
wikibase:identifiers 39
wikibase:sitelinks 11
wikibase:statements 100
p:P10245 wd:statement/Q7914515-e481dc4a-45d1-d72c-749d-431482fc0816
p:P10283 wd:statement/Q7914515-EBEE3B87-2B0F-4213-9172-750AC923C2A0
p:P11089 wd:statement/Q7914515-DB7DC721-0457-43CE-BF4B-500735699C95
p:P11143 wd:statement/Q7914515-76AA5882-E506-45F9-948D-FC2BF215A462
p:P11198 wd:statement/Q7914515-53AEE5BB-B700-4CD3-8A34-1F191ACAD6B3
p:P11199 wd:statement/Q7914515-F2B834E4-2B0A-49FB-A5A3-026CDCD06C32
p:P117 wd:statement/Q7914515-b0e3474b-48ab-35e0-218b-a72b3159c9b1
p:P129 wd:statement/Q7914515-1940B970-3256-4D3E-93DC-E2B8F35503A7
wd:statement/Q7914515-1A1FEAFD-826E-46E5-903A-88AD975CF1C7
wd:statement/Q7914515-9ECEDDE4-C52D-46DD-865D-42C2875D998F
p:P1579 wd:statement/Q7914515-9D71A660-67EC-44EE-959E-131809B303F3
p:P2062 wd:statement/Q7914515-DEB494A5-4B75-459C-9CBB-6BBD4DCF2E1A
p:P2067 wd:statement/Q7914515-2A00DA37-BD98-43A4-ABCC-72AB6772C505
p:P2115 wd:statement/Q7914515-98A2E496-870E-4120-913D-0FB3789A2AD6
p:P2175 wd:statement/Q7914515-70BF6714-9876-4DD0-BFD4-AB6F10441BDB
wd:statement/Q7914515-D1EA3D84-5A2D-48BF-92C9-B562A856887B
p:P231 wd:statement/Q7914515-E89E4B69-5873-4080-A580-757403367B8B
p:P232 wd:statement/Q7914515-11105C79-A619-4347-9832-C7C44AD8BEE5
p:P233 wd:statement/Q7914515-90BC468B-73BB-4D15-B078-444A3B8B3A49
p:P234 wd:statement/Q7914515-9DCA741E-280D-4D87-AFE2-C68902A51F26
p:P235 wd:statement/Q7914515-CAB132F8-2136-4EEE-9FF2-BA9B840A5AB1
p:P2566 wd:statement/Q7914515-13572468-2468-1357-eca9-bdf024681357
p:P267 wd:statement/Q7914515-68CE9F66-068D-4AF9-BC17-AAFC192EEA8C
p:P274 wd:statement/Q7914515-6E20A401-CD18-40C5-9756-DE6F2DF8112A
p:P279 wd:statement/Q7914515-FD552118-0490-43FB-A8FD-D80C799B69D9
p:P2840 wd:statement/Q7914515-271E4F9B-6D6E-425F-ADC7-593113ADB6A4
wd:statement/Q7914515-F3812AF3-ECB3-48F2-ADDD-83DDEB1BA554
p:P2868 wd:statement/Q7914515-95508343-355B-4ADB-8E84-C517B0506DCB
p:P2877 wd:statement/Q7914515-C6178DC6-ED26-42C6-A66E-E047B9FF1ACE
p:P2892 wd:statement/Q7914515-9601BAE4-9F25-47B9-9D3E-439F638B803D
wd:statement/Q7914515-B3815069-9FEF-405B-A2F0-D047F13404F4
p:P31 wd:statement/Q7914515-053F6634-6759-4D85-B810-CD37E9433E71
p:P3117 wd:statement/Q7914515-DC99DFCC-F92A-40A1-8FB0-8E3F0759AB9C
p:P3345 wd:statement/Q7914515-B5B63786-1740-477F-B991-22911254A69A
p:P3489 wd:statement/Q7914515-CC9BEACB-BB56-482E-BF8C-BA179A4C557C
wd:statement/Q7914515-F73D2787-04C9-49FA-B055-CA097D08612F
p:P3493 wd:statement/Q7914515-4E1A2E1F-83F9-4F4F-94F5-0FD332FE0402
p:P3636 wd:statement/Q7914515-DC3570A9-B3A1-45F0-8695-D1213E5F6752
p:P366 wd:statement/Q7914515-2B43E913-1EF6-450F-992D-542FFC007DB0
p:P373 wd:statement/Q7914515-f825044f-e791-4ba2-97bc-573e7f313399
p:P3780 wd:statement/Q7914515-06DE590B-5407-49C9-8F0D-9AEF0A08F35C
p:P4527 wd:statement/Q7914515-11259840-F32A-4FDC-97D5-9A00B23C94A9
p:P486 wd:statement/Q7914515-6fc03758-45ea-7db9-9fa8-dd2a7d913bfa
p:P4964 wd:statement/Q7914515-E2AEA910-D028-4854-ABFD-3E1CFBA937A4
p:P592 wd:statement/Q7914515-6CC0A68B-7061-46BF-9D2D-937A1C9EC934
p:P595 wd:statement/Q7914515-81343718-3816-4F1D-A680-82108130DDDA
p:P6366 wd:statement/Q7914515-E51FC50E-B308-44C4-A963-46E0ECB8BA55
p:P638 wd:statement/Q7914515-AFDB156D-9ED5-4783-979B-05A7D3F3D3AD
p:P646 wd:statement/Q7914515-4C617312-EF43-416B-89E3-0A3F6F428914
p:P652 wd:statement/Q7914515-7B131817-5C6E-4766-8384-B2342A217630
p:P661 wd:statement/Q7914515-1E31266A-6B0D-48B5-B567-4B73DB812FAE
p:P662 wd:statement/Q7914515-9AB9AB8B-BFFF-441A-B01A-B5EE01F2D514
p:P665 wd:statement/Q7914515-00003C58-87D0-4A8E-B897-B18542CD0A51
p:P683 wd:statement/Q7914515-502742E5-63B2-4D8E-93C1-E097B7F4070C
p:P715 wd:statement/Q7914515-7A684CDA-4E73-4581-AB0E-34A2C1675CF6
p:P769 wd:statement/Q7914515-05A44EA5-3FB4-4ABC-A810-4CEE37869210
wd:statement/Q7914515-05BF35DB-FA58-41D7-978A-BEBCEDB7EF61
wd:statement/Q7914515-0E8FEFE8-2E82-4DCE-8458-F85946AB61E7
wd:statement/Q7914515-0F2D9C68-9A9D-4FC9-9E35-EBC62DB3C04E
wd:statement/Q7914515-0F87CCD8-6644-4CE6-97F5-563AE5164099
wd:statement/Q7914515-1E3F596B-687E-453A-A35D-D94FC24F0EF1
wd:statement/Q7914515-26461FA9-D227-4ED6-B78F-CA48667F04B3
wd:statement/Q7914515-28E37A5C-CA63-4641-B67B-C527D29D51FF
wd:statement/Q7914515-2B7E5269-1982-484D-844B-ED800D37F4EB
wd:statement/Q7914515-2C9F37C4-C2C0-45CF-90EB-989318BD8FA9
wd:statement/Q7914515-310AF43B-B1BD-4953-8564-A2AB3E807870
wd:statement/Q7914515-32030AF0-93E3-459D-BEEC-C4F3F7180E3E
wd:statement/Q7914515-3F23B503-D7CD-447E-8033-15678D47B273
wd:statement/Q7914515-484ECAD5-0A8B-42EE-BBA9-0A42C57243FF
wd:statement/Q7914515-4C2C7AA1-2745-403E-8BA3-D0AD6D76FAC0
wd:statement/Q7914515-5DF76F4D-AD48-4374-8F98-1336899FF52A
wd:statement/Q7914515-5EBED3A8-DDB8-4057-85B3-38C6F264F971
wd:statement/Q7914515-6B1670AF-F4E1-45B7-BEA5-AD875C8FED88
wd:statement/Q7914515-712CBDBC-6EB1-459B-AC82-2CD8F8E6023C
wd:statement/Q7914515-7617B16D-C2EE-4F34-A725-2DD0810DC5C0
wd:statement/Q7914515-7BF65F34-4DB5-406F-BA1A-E2FE8A286983
wd:statement/Q7914515-7CD486EA-058C-4631-9854-A7FAA03FEAF8
wd:statement/Q7914515-7E610491-4ACC-47F7-B577-77BBDEA00451
wd:statement/Q7914515-7F64C7FF-743B-4312-A17C-D71B35875C7D
wd:statement/Q7914515-847D320A-53CD-4D0E-9B50-2647DC11B2D7
wd:statement/Q7914515-8D6FA50D-5BEC-4823-B5DB-9B6359FA4CA9
wd:statement/Q7914515-8E6F9D8D-0E35-4068-8AAB-886718537B65
wd:statement/Q7914515-92EF2235-89E3-47BC-B789-F478DCE8DA52
wd:statement/Q7914515-9F429C7E-6908-4AD9-BF15-735F5A2CFF17
wd:statement/Q7914515-A17A4F05-66B9-4E29-BA39-BBAC4A96FC3C
wd:statement/Q7914515-A1974134-B948-4CE9-8B52-D4A23936CDF6
wd:statement/Q7914515-A9E11A1B-401C-4989-A96A-7A37AB7D68AC
wd:statement/Q7914515-AC360A1C-C7BC-461F-956D-FA91D6442C0C
wd:statement/Q7914515-AD3DE0A6-AD36-4F94-85B8-313A9E02EACA
wd:statement/Q7914515-B479C4D2-C1CF-4DE7-A6E1-4F3DB2BAE2F8
wd:statement/Q7914515-B48D7F09-82AF-49EF-9AF4-6A83AA8FDBA0
wd:statement/Q7914515-BAFE128D-B8C2-4738-80A1-DB13A2BE1342
wd:statement/Q7914515-C8B02FE4-A3FD-42D8-A06E-42880D36208D
wd:statement/Q7914515-CA9FB2FB-44FA-4EA8-A74A-D3F1A465CD72
wd:statement/Q7914515-CAAADEB5-A547-4C1A-AB3F-10E283C76847
wd:statement/Q7914515-EF47FD2C-5F27-4210-B094-C24460F43569
wd:statement/Q7914515-FF50D586-9140-4BDD-BC92-DA179F7BEAB8
p:P7830 wd:statement/Q7914515-DAA395EB-E557-4AA0-A361-0BE2102B5F10
p:P8026 wd:statement/Q7914515-5AC34949-7083-43BC-9899-899A4A8B8318
p:P8494 wd:statement/Q7914515-ADDEB5D9-E58B-459C-AFD0-C144AD5E9534
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000182736>
p:direct-normalized/P4527 <http://data.parliament.uk/terms/434250>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/C452423>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL24828>
p:direct-normalized/P6366 <https://makg.org/entity/2780333294>
p:direct-normalized/P638 <https://rdf.wwpdb.org/pdb/2IVU>
p:direct-normalized/P661 <http://rdf.chemspider.com/2338979>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361>
p:direct-normalized/P665 <http://www.kegg.jp/entry/D06407>
p:direct-normalized/P683 <http://purl.obolibrary.org/obo/CHEBI_49960>
wdt:P10245 "a612007"
wdt:P10283 "C2780333294"
wdt:P11089 "263028"
wdt:P11143 "Vandetanib"
wdt:P11198 "4178"
wdt:P11199 "PD003329"
wdt:P117 <http://commons.wikimedia.org/wiki/Special:FilePath/Vandetanib2DACS.svg>
wdt:P129 kinase insert domain receptor
ret proto-oncogene
epidermal growth factor receptor
wdt:P1579 "9161676"
wdt:P2062 "8198"
wdt:P2067 474.107^^xsd:decimal
wdt:P2115 "N0000182736"
wdt:P2175 thyroid medullary carcinoma
thyroid cancer
wdt:P231 "443913-73-3"
wdt:P232 "669-841-4"
wdt:P233 "CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC"
wdt:P234 "InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)"
wdt:P235 "UHTHHESEBZOYNR-UHFFFAOYSA-N"
wdt:P2566 "100.195.611"
wdt:P267 "L01XE12"
wdt:P274 "C₂₂H₂₄BrFN₄O₂"
wdt:P279 chemical compound
wdt:P2840 "744325"
"760766"
wdt:P2868 protein kinase inhibitors
wdt:P2877 "9044"
wdt:P2892 "C1121849"
"C1628324"
wdt:P31 type of chemical entity
wdt:P3117 "DTXSID1046681"
wdt:P3345 "1098413"
wdt:P3489 US pregnancy category D
Australian pregnancy category D
wdt:P3493 boxed warning
wdt:P3636 "ZD6"
wdt:P366 medication
wdt:P373 "Vandetanib"
wdt:P3780 Caprelsa
wdt:P4527 "434250"
wdt:P486 "C452423"
wdt:P4964 "splash10-000i-0293000000-9037b32a179af5e7ba9a"
wdt:P592 "CHEMBL24828"
wdt:P595 "5717"
wdt:P6366 "2780333294"
wdt:P638 "2IVU"
wdt:P646 "/m/026m12g"
wdt:P652 "YO460OQ37K"
wdt:P661 "2338979"
wdt:P662 "3081361"
wdt:P665 "D06407"
wdt:P683 "49960"
wdt:P715 "DB05294"
wdt:P769 clarithromycin
pimozide
droperidol
(RS)-methadone
erythromycin
zuclopenthixol
haloperidol
pasireotide
(Z)-Toremifene
chlorpromazine
anagrelide
dronedarone
(RS)-citalopram
ondansetron
amiodarone
voriconazole
sotalol
pentamidine
(RS)-hydroxyzine
(RS)-sulpiride
domperidone
moxifloxacin
disopyramide
fingolimod
ivabradine
crizotinib
fosphenytoin
mefloquine
arsenic trioxide
wdt:P7830 "Vandetanib"
wdt:P8026 LiverTox toxicity likelihood category E*
wdt:P8494 "DTXCID9026681"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata